Cargando…

FDG–PET. A possible prognostic factor in head and neck cancer

Previous studies have shown that high uptake of (18)F-fluoro-2-deoxy-glucose in head and neck cancer, as determined by the standardized uptake value on positron emission tomography scan, was associated with poor survival. The aim of this study was to confirm the association and to establish whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Halfpenny, W, Hain, S F, Biassoni, L, Maisey, M N, Sherman, J A, McGurk, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375291/
https://www.ncbi.nlm.nih.gov/pubmed/11870529
http://dx.doi.org/10.1038/sj.bjc.6600114
_version_ 1782154622245273600
author Halfpenny, W
Hain, S F
Biassoni, L
Maisey, M N
Sherman, J A
McGurk, M
author_facet Halfpenny, W
Hain, S F
Biassoni, L
Maisey, M N
Sherman, J A
McGurk, M
author_sort Halfpenny, W
collection PubMed
description Previous studies have shown that high uptake of (18)F-fluoro-2-deoxy-glucose in head and neck cancer, as determined by the standardized uptake value on positron emission tomography scan, was associated with poor survival. The aim of this study was to confirm the association and to establish whether a high standardized uptake value had prognostic significance. Seventy-three consecutive patients with newly diagnosed squamous cell carcinoma of the head and neck underwent a positron emission tomography study before treatment. Age, gender, performance status tumour grade, stage, maximal tumour diameter and standardized uptake value were analyzed for their possible association with survival. The median standardized uptake value for all primary tumours was 7.16 (90% range 2.30 to 18.60). In univariate survival analysis the cumulative survival was decreased as the stage, tumour diameter and standardized uptake value increased. An standardized uptake value of 10 was taken as a cut-off for high and low uptake tumours. When these two groups were compared, an standardized uptake value >10 predicted for significantly worse outcome (P=0.003). Multivariate analysis demonstrated that an standardized uptake value >10 provided prognostic information independent of the tumour stage and diameter (P=0.002). We conclude that high FDG uptake (standardized uptake value>10) on positron emission tomography is an important marker for poor outcome in primary squamous cell carcinoma of the head and neck. Standardized uptake value may be useful in distinguishing those tumours with a more aggressive biological nature and hence identifying patients that require intensive treatment protocols including hyperfractionated radiotherapy and/or chemotherapy. British Journal of Cancer (2002) 86, 512–516. DOI: 10.1038/sj/bjc/6600114 www.bjcancer.com © 2002 Cancer Research UK
format Text
id pubmed-2375291
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23752912009-09-10 FDG–PET. A possible prognostic factor in head and neck cancer Halfpenny, W Hain, S F Biassoni, L Maisey, M N Sherman, J A McGurk, M Br J Cancer Clinical Previous studies have shown that high uptake of (18)F-fluoro-2-deoxy-glucose in head and neck cancer, as determined by the standardized uptake value on positron emission tomography scan, was associated with poor survival. The aim of this study was to confirm the association and to establish whether a high standardized uptake value had prognostic significance. Seventy-three consecutive patients with newly diagnosed squamous cell carcinoma of the head and neck underwent a positron emission tomography study before treatment. Age, gender, performance status tumour grade, stage, maximal tumour diameter and standardized uptake value were analyzed for their possible association with survival. The median standardized uptake value for all primary tumours was 7.16 (90% range 2.30 to 18.60). In univariate survival analysis the cumulative survival was decreased as the stage, tumour diameter and standardized uptake value increased. An standardized uptake value of 10 was taken as a cut-off for high and low uptake tumours. When these two groups were compared, an standardized uptake value >10 predicted for significantly worse outcome (P=0.003). Multivariate analysis demonstrated that an standardized uptake value >10 provided prognostic information independent of the tumour stage and diameter (P=0.002). We conclude that high FDG uptake (standardized uptake value>10) on positron emission tomography is an important marker for poor outcome in primary squamous cell carcinoma of the head and neck. Standardized uptake value may be useful in distinguishing those tumours with a more aggressive biological nature and hence identifying patients that require intensive treatment protocols including hyperfractionated radiotherapy and/or chemotherapy. British Journal of Cancer (2002) 86, 512–516. DOI: 10.1038/sj/bjc/6600114 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-02-12 /pmc/articles/PMC2375291/ /pubmed/11870529 http://dx.doi.org/10.1038/sj.bjc.6600114 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical
Halfpenny, W
Hain, S F
Biassoni, L
Maisey, M N
Sherman, J A
McGurk, M
FDG–PET. A possible prognostic factor in head and neck cancer
title FDG–PET. A possible prognostic factor in head and neck cancer
title_full FDG–PET. A possible prognostic factor in head and neck cancer
title_fullStr FDG–PET. A possible prognostic factor in head and neck cancer
title_full_unstemmed FDG–PET. A possible prognostic factor in head and neck cancer
title_short FDG–PET. A possible prognostic factor in head and neck cancer
title_sort fdg–pet. a possible prognostic factor in head and neck cancer
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375291/
https://www.ncbi.nlm.nih.gov/pubmed/11870529
http://dx.doi.org/10.1038/sj.bjc.6600114
work_keys_str_mv AT halfpennyw fdgpetapossibleprognosticfactorinheadandneckcancer
AT hainsf fdgpetapossibleprognosticfactorinheadandneckcancer
AT biassonil fdgpetapossibleprognosticfactorinheadandneckcancer
AT maiseymn fdgpetapossibleprognosticfactorinheadandneckcancer
AT shermanja fdgpetapossibleprognosticfactorinheadandneckcancer
AT mcgurkm fdgpetapossibleprognosticfactorinheadandneckcancer